-
Early Economic Modeling of Mutant TNF (mutTNF) As a BBB-Permeabilizing Adjunct in Breast Cancer Brain Metastases: A UK NHS Perspective
Sep 9, 2025, 16:22 PM -
Are We There Yet? Mapping Member State Readiness for Local Implementation of the EU Health Technology Assessment (HTA) Regulation
Sep 9, 2025, 16:22 PM -
Bridging the Gap: What Spain Can Learn From European Leaders in Digital Therapy Reimbursement
Sep 9, 2025, 16:22 PM -
Challenges and Opportunities in the Dutch Lock Procedure Improving Access and Reimbursement Timelines for Cell and Gene Therapies in the Netherlands
Sep 9, 2025, 16:22 PM -
Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version
Sep 9, 2025, 16:22 PM -
Challenges in PICO Definition for HTDs: Lessons From Durvalumab Exercise
Sep 9, 2025, 16:22 PM -
Structural Uncertainty (SU) in Model-Based Economics Appraisal (MBEA): A Document Review of the French National Authority for Health (HAS)
Sep 9, 2025, 16:22 PM -
AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada
Sep 9, 2025, 16:22 PM -
Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries
Sep 9, 2025, 16:22 PM -
The Role of a Functional Clinical Staff in Guiding High-Cost Drug and Novel Technology Decision Making: Experience From a Latin American Oncology Clinic
Sep 9, 2025, 16:22 PM -
Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany
Sep 9, 2025, 16:22 PM -
Innovation in Off-Patent Competitive Environment: Key Learnings From Successes and Failures
Sep 9, 2025, 16:22 PM -
Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment On Healthcare Resource Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Cost-Substitution and Hospital Diagnosis-Related Group (DRG) Performance Impact Analysis of Infliximab Biosimilar Adoption in Moderate-to-Severe Crohn's Disease Patients in China
Sep 9, 2025, 16:22 PM -
Defining Decision-Making Criteria for Glaucoma Surgery in Non-Refractory, Moderate to Severe Open-Angle Glaucoma: A Stakeholder Analysis Across Multiple Countries with Distinct Payer Archetypes to Support a Multi-Criteria Decision Analysis Framework
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Linzagolix 200 mg Plus Add-back Therapy (Linzagolix+ABT) for Symptomatic Treatment of Endometriosis
Sep 9, 2025, 16:22 PM -
Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Tenecteplase for the Intravenous Thrombolysis Treatment of Acute Ischemic Stroke in China
Sep 9, 2025, 16:22 PM